跳至主要内容
临床试验/JPRN-UMIN000011215
JPRN-UMIN000011215招募中未知

Feasibility study of adjuvant chemotherapy with nanoparticle albumin-bound (nab)- paclitaxel and carboplatin in patients with completely resected pathological IB non small cell lung cancer - Feasibility study of adjuvant chemotherapy with nanoparticle albumin-bound (nab)- paclitaxel and carboplatin in patients with completely resected pathological IB non small cell lung cancer

Department of Thoracic Surgery , Faculty of Life Science Kumamoto University0 个研究点目标入组 35 人开始时间: 2013年7月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Anamnesis of hypersensitivity to drugs 2)Massive pleural or pericardial effusion 3)With active double cancer 4)Severe complication (ileus , interstitial pneumonia , interstitial pneumonia , pulmonary fibrosis, uncontrolled diabetes , heart failure , renal failure, hepatic failure, and so on) 5) With active infections 6) With a difficult bowel movement 7) Pleural effusion, cardiac effusion, or cardiac effusion necessitating treatment. 8) Pregnancy or lactating patients 9) Uncontrolled psychiatric disease 10)With poor-controlled diabetes mellitus 11) Concurrent steroid therapy 12) With HBs or HCV 13) With HIV 14) Physician judged improper to entry this trial

研究者

发起方
Department of Thoracic Surgery , Faculty of Life Science Kumamoto University

相似试验

Feasibility study of adjuvant chemotherapy with... | 临床试验